Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for Transcept Pharmaceuticals, Inc. > News item |
Transcept files $75 million shelf covering stock, debt and preferreds
By Devika Patel
Knoxville, Tenn., June 17 - Transcept Pharmaceuticals, Inc. filed a $75 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers common stock, preferred stock, debt securities, depositary shares and warrants.
The securities may be structured as convertibles.
Proceeds will be used for general corporate purposes.
Transcept is a Point Richmond, Calif.-based pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.